Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer
2017729 citationsAngela M. Krebs, Julia Mitschke et al.Nature Cell Biologyprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of M Losada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Losada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Losada more than expected).
This network shows the impact of papers produced by M Losada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Losada. The network helps show where M Losada may publish in the future.
Co-authorship network of co-authors of M Losada
This figure shows the co-authorship network connecting the top 25 collaborators of M Losada.
A scholar is included among the top collaborators of M Losada based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with M Losada. M Losada is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Krebs, Angela M., Julia Mitschke, M Losada, et al.. (2017). The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Nature Cell Biology. 19(5). 518–529.729 indexed citations breakdown →
Viaño, J., et al.. (1982). [Focal, relapsing neurological manifestations as the main signs of systemic lupus erythematosus].. PubMed. 79(1). 39–42.1 indexed citations
10.
Macera, Caroline A., et al.. (1977). [HLA-B27 antigen in ankylosing spondylitis and other forms of rheumatism (author's transl)].. PubMed. 105(2). 90–2.1 indexed citations
11.
Losada, M, Tahany Awad, & Sebastián Donoso. (1970). [Clinico-anatomical correlation in systemic lupus erythematosus].. PubMed. 98(9). 586–94.1 indexed citations
12.
Awad, T., M Losada, & Antonio Losada. (1967). [Treatment of scapulo-humeral periarthritis with alpha-chymotrypsin and rehabilitation].. PubMed. 95(7). 372–6.1 indexed citations
13.
Hurtado, Rocio, et al.. (1963). [THE REACTIONS OF WAALER-ROSE AND OF LATEX IN RHEUMATOID ARTHRITIS].. PubMed. 91. 902–7.1 indexed citations
14.
Medina, E & M Losada. (1960). [Epidemiology of rheumatism in Chile].. PubMed. 88. 454–62.2 indexed citations
15.
Losada, M, et al.. (1953). [Laboratory aspects of rheumatoid arthritis].. PubMed. 50(3). 203–12.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.